Long-term financing strengthens Mölnlycke Health Care’s global expansion
Mölnlycke Health Care is a world-leading medical technology company with a strong international presence in wound care and surgery. The company’s products and solutions are used daily by hospitals, healthcare providers and patients in over 100 countries, contributing to the development of healthcare globally.
Strategic financing strengthens international growth
To support continued global growth and accelerate strategic development initiatives, Mölnlycke has signed a USD 400 million financing agreement with SEK. The ten-year financing solution creates stable and long-term conditions for the company’s international expansion strategy.
The financing strengthens Mölnlycke’s financial freedom of action at a time when the healthcare sector is undergoing rapid change and the demands for innovative, efficient and sustainable solutions are increasing. The collaboration with SEK constitutes an important support as the company enters the next phase of its customer-centric strategy.
Facts
- Offer and purpose: Long-term operating and expansion financing
- Amount: USD 400 million
- Maturity: 10 years
- Borrower: Mölnlycke Health Care AB
Do you want to know more?
Klas Lindgren Dansbo, Head of Large Corporates
Which financing solution was used?